Research News
Time Interval from Surgery to Chemo Impacts Prognosis in Ovarian Cancer
Researchers in Austria investigated whether the time interval from surgery to start of chemotherapy has an impact on clinical outcome in patients with advanced serous ovarian cancer…
Ovarian Cancer Therapies in Development
Dr. Coleman, a member of the Alliance’s Scientific and Medical Advisory Board, conducted an interview on ovarian cancer therapies for the Cancer Network…
Analysis Points to New Cell Lines as Tumor Models for Ovarian Cancer Research
Research published online last week in Nature Communications suggests that some of the cell lines most frequently used to study high-grade serous ovarian cancer (HGSOC) may not be the best…
Progesterone and Estrogen Receptors are Prognostic Biomarkers for Some Ovarian Cancers
In an article published last week in The Lancet, an international group of investigators examined whether ovarian cancer tumors’ expression of the progesterone receptor (PR) and estrogen receptor (ER) was associated with survival in various…
Family History of Breast Cancer but no Genetic Mutation Does Not Raise Risk of Ovarian Cancer
Women with a family history of breast cancer but no BRCA1/2 mutation were found to be at average risk for developing ovarian cancer…
OCRF Talk with Lin Zhang, M.D.
In an interview, 3-time grantee Dr. Zhang discusses his research and what it means to receive an award from OCRF…
Report from ASCO 2013–What's New in Ovarian Cancer Research
We recently returned from the annual meeting of the American Society of Clinical Oncology (ASCO), an annual event that gathers thousands of cancer researchers from around the world…
Supreme Court Strikes Down BRCA Gene Patents
In a unanimous ruling issued June 13, 2013, the US Supreme Court ruled that private companies do not have the right to patent human genes. In Association for Molecular Pathology et al. v…
June 2013 SNMMI Meeting
Society for Nuclear Medicine and Molecular Imaging (SNMMI) Advocate Report from Laurel Pracht As a member of the SNMMI Advocate Advisory Board, formed in 2010 to better bridge the gap between the patient and nuclear medicine communities, I represent…
Press Release: Ovarian Cancer Advocates Praise Supreme Court Decision on Gene Patents
Ruling Will Give Women More Options to Learn About Genetic Risk Washington, DC—The Supreme Court ruled today that a company cannot patent naturally occurring genes, including isolated gene segments, overturning a decision made by the United States…
New Meta-Analysis of Oral Contraception and Risk of Ovarian Cancer
A new meta-analysis of more than 6000 studies shows that oral contraceptives significantly reduce the risk of ovarian cancer. The risk reduction increases proportionally with duration of use…
ASCO News: Weekly Chemo Improves Quality of Life
In research presented at the American Society of Clinical Oncology meeting this week, researchers found that shortening the break between chemotherapy sessions improved quality of life for patients, without negatively impacting efficacy…